‘Significant distress to patients’

Recent supply shortages for first-line migraine meds hit patients hard and increased workloads, according to a PBAC stakeholder meeting Calcitonin gene-related peptide (CRGP) therapies are recommended as first-line medications for prevention of chronic migraine but patients and health practitioners have been impacted by shortages, according to a stakeholder meeting chaired by the Pharmaceutical Benefits Advisory